RXi Pharmaceuticals Corporation (RXII) declined -5.03% or -0.09 to $1.7. It is about 196970 shares traded, which is 33.01% compare to the average total volume 596782. The market cap of RXII is $7.23 million. The year to date change is -72.48%. The 52 week price range is from $1.29 to $7.7. Price of RXII have changed 21.77% during last week. It have changed -8.67% over last month, -31.42% over last 3 months, -58.28% over last 6 months and -70.08% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for RXII is 2.06. It is 21.18% above current price. The 200-day Moving Averages for RXII is 3.73. It is 119.41% above current price. The 52-week High is 7.7. It is 352.94% from the current price. The 52-week Low is 1.29. It is -24.12% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of RXII is 3.63 on 2018-07-13. Short % to float is 16.14%. There are some statistics of RXII. It is has market cap $7.23 million. The share outstanding is 4.26 million. The average volume is 596782. The percent of top 15 Institution holding is 54.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of RXII is -182.60%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of RXII is -121.02%.